Skip to main content

News

By Susan Morse | 10:49 am | October 18, 2022
Humana, which has also reportedly shown interest, has the right of first refusal in a sale.
By Jeff Lagasse | 04:37 pm | October 17, 2022
The administration will task HHS and CMMI with testing new models that are shown to improve quality and lower costs.
By Jeff Lagasse | 02:28 pm | October 17, 2022
Medicare enrollees will also see lower costs for insulin and vaccines beginning in 2023, according to HHS.
By Jeff Lagasse | 11:43 am | October 17, 2022
Other top headlines this past week include a look at how telemedicine can improve orthopedic care.
By Susan Morse | 04:28 pm | October 14, 2022
The current 90-day extension ends on January 11, 2023.
By Jeff Lagasse | 04:17 pm | October 14, 2022
Of the MGMA survey respondents, 89% said the overall regulatory burden on their practice has increased over the past 12 months.
By Jeff Lagasse | 12:00 pm | October 14, 2022
The plan provides flexibility for veterans to see in-network local doctors and fill prescriptions at nearby pharmacies, outside the VA system.
By Susan Morse | 11:12 am | October 14, 2022
Less competition and more vertical integration can embolden anti-competitive business practices to the detriment of patients, says AMA president.
By Jeff Lagasse | 04:52 pm | October 13, 2022
The figures are consistent with the trend of falling below prepandemic deal numbers, though two 'mega' transactions occurred.
By Jeff Lagasse | 12:36 pm | October 13, 2022
The goal was to bring cancer treatments to the market at a cost, scale and efficacy that would have maximum impact.